Pharmaceutical Sciences · 2025–2026

From pharmaceutics to translational health research.

I am an M1 student in Development of Drugs and Health Products (D2HP) at Université Paris-Saclay. My work connects pharmaceutical technology, drug delivery, natural products, and data-informed clinical research.

4Publications
3Research themes
4Institutions

Research focus

Research focus

I am interested in how formulation science, experimental pharmacology, and population data can work together to improve medicines and health outcomes.

01

Pharmaceutical technology

Hot-melt extrusion, polymer-based filaments, and the potential of fused deposition modeling for tablet manufacturing.

02

Metabolic and cardiovascular health

Biomarkers, clinical epidemiology, and experimental approaches to diabetes and cardiovascular risk.

03

Natural products and drug delivery

Analytical chemistry, network pharmacology, molecular docking, and modern delivery strategies for bioactive compounds.

Latest highlights

See all experience

Research internship at the University of Szeged

Hot-melt extrusion of HPMC-based filaments for potential FDM tablet printing, supervised by Dr. habil. Tamás Sovány.

New article published in Medicine

A cross-sectional NHANES study evaluating UHR as a predictor of cardiovascular disease in cancer patients.

M1 D2HP at Université Paris-Saclay

International training across drug development, pharmaceutical sciences, and health products.

Education

M1 Development of Drugs and Health Products (D2HP)

Faculty of Pharmacy, Université Paris-Saclay

B.S. in Pharmaceutic Preparations

Heilongjiang University of Chinese Medicine

Full education history

Selected publications

View all publications
01

Medicine · 2026-01-02

The predictive performance of the uric acid-to-high-density lipoprotein cholesterol ratio (UHR) for cardiovascular diseases in cancer patients: A cross-sectional study from NHANES

Yuning Gu; Chuanran Qin

DOI ↗
02

Journal of Functional Foods · 125, 106652 · 2025

Active ingredients and mechanisms of peony seed blended oil in diabetes treatment using Kunming mice: Insights from GC–MS, network pharmacology, and experimental verification

Yuning Gu; Fengliang Zhong; Tiantian Sun; Zirui Chang

DOI ↗
03

Journal of Clinical Medicine Research · 5(2), 151–158 · 2024

Study on the in vitro inhibitory activity of peony seed blended oil on α-amylase and α-glucosidase

Tiantian Sun; Zirui Chang; Fengliang Zhong; Zishu Li; Yu Fu; Yuning Gu

DOI ↗

Let’s connect

Let’s connect

I welcome conversations about pharmaceutical technology, drug development, clinical research, and international research opportunities.

Email me